Proposed cuts to Medicaid could undo advances in treatment for opioid use disorders, risking more overdoses, deaths and stress on the U.S. health system ...

Prescribing Opioids to Older Adults: A Guide to Choosing and Switching Among Them Marc Ginsburg, RN, MScN, NP; Shawna Silver, MD, PEng; Hershl Berman, MD, FRCPC Disclosures ...

OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it. A judge on Wednesday is bein ...

Purdue Pharma and the family who previously owned the company will have to pay more than $7 billion for it's role in the opioid epidemic. It's the largest settlement in American history.

All 50 states, D.C., and four U.S. territories signed off on the multi-billion dollar settlement proposal with OxyContin maker Purdue Pharma in litigation over Purdue's alleged role in America's ...

Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker and its ...

All 55 attorneys general that represented all eligible states and U.S. territories, agreed to sign on to a $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family. The once ...

55 attorneys general that have preliminarily agreed to a $7.4 billion settlement with Purdue Pharma for their role in the opioid epidemic.

Pennsylvania could receive up to $200 million over a period of 15 years as part of a settlement with Purdue Pharma and its owners, the Sackler family.

All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.

Purdue Pharma has won support from the attorneys general of 55 states including Ohio for its $7.4 billion settlement to resolve opioid lawsuits .

June 16, 2025 Purdue Pharma's $7.4 billion opioid settlement will pay $200 million to Pa. and $125 million to N.J. The deal also bars the Sackler family, the longtime owners of pharmaceutical ...